|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
4/19/22 Oncocyte Corp. 8-K:1,8,9 4/13/22 15:750K M2 Compliance LLC/FA
4/15/22 Broadwood Partners, L.P. 4 10% Owner² 1:20K Oncocyte Corp. Seward & Kissel LLP
Bradsher Neal C
Broadwood Capital Inc.
4/13/22 Oncocyte Corp. 424B5 1:442K M2 Compliance LLC/FA
4/13/22 Oncocyte Corp. 8-K:1,5,8,9 4/13/22 14:708K M2 Compliance LLC/FA
____________ | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 424B5 | Prospectus – Primary Offering or Shelf Securities – New Facts or Events. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|